ESMO-led Anti-Cancer Medicines Availability Study

Your assistance would be appreciated on three actions:

1. Review the data online - select the tumour types you wish to review
2. Leave any comments online or mail them to Nathan Cherny
3. Please forward this study to colleagues for their review

This far-reaching study will have an important impact on the current medical landscape and aims to have long-term, hard-hitting consequences on medicine accessibility for patients across Europe.

Useful info

Please paste this url into your browser should you encounter problems
https://eu.qualtrics.com/SE/?SID=SV_8xdgeNHUhBJ4yuF
 
Please visit this page for helpful tips on reviewing data